{
    "id": 29331,
    "fullName": "SMO G497W",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "SMO G497W lies within an extracellular domain of the Smo protein (UniProt.org). G497W is predicted to confer resistance to Hedgehog pathway inhibitors based on structural modeling (PMID: 25306392), but has not been biochemically characterized and therefore, its effect on Smo protein function is unknown (PubMed, Apr 2020).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 12487,
                    "pubMedId": 25306392,
                    "title": "Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25306392"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 6608,
        "geneSymbol": "SMO",
        "terms": [
            "SMO",
            "CRJS",
            "FZD11",
            "Gx",
            "SMOH"
        ]
    },
    "variant": "G497W",
    "createDate": "02/12/2019",
    "updateDate": "04/02/2020",
    "referenceTranscriptCoordinates": {
        "id": 178554,
        "transcript": "NM_005631",
        "gDna": "chr7:g.129210385G>T",
        "cDna": "c.1489G>T",
        "protein": "p.G497W",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15949,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a basal cell carcinoma patient who did not respond to Erivedge (vismodegib) during a Phase II trial was found to harbor a SMO G497W mutation in the initial and progressing lesions (PMID: 25306392; NCT01367665).",
            "molecularProfile": {
                "id": 31336,
                "profileName": "SMO G497W"
            },
            "therapy": {
                "id": 956,
                "therapyName": "Vismodegib",
                "synonyms": null
            },
            "indication": {
                "id": 2513,
                "name": "basal cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 12487,
                    "pubMedId": 25306392,
                    "title": "Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25306392"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31336,
            "profileName": "SMO G497W",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 178554,
            "transcript": "NM_005631",
            "gDna": "chr7:g.129210385G>T",
            "cDna": "c.1489G>T",
            "protein": "p.G497W",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}